229 related articles for article (PubMed ID: 9418147)
1. CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues.
Bahar R; Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Dec; 26(6):443-6. PubMed ID: 9418147
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
[TBL] [Abstract][Full Text] [Related]
3. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis.
Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Aug; 26(4):280-3. PubMed ID: 9258720
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
[TBL] [Abstract][Full Text] [Related]
5. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
7. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
8. Stromelysin-3 expression is an early event in human oral tumorigenesis.
Soni S; Mathur M; Shukla NK; Deo SV; Ralhan R
Int J Cancer; 2003 Nov; 107(2):309-16. PubMed ID: 12949813
[TBL] [Abstract][Full Text] [Related]
9. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan.
Kuo MY; Chang HH; Hahn LJ; Wang JT; Chiang CP
J Oral Pathol Med; 1995 Jul; 24(6):255-60. PubMed ID: 7562661
[TBL] [Abstract][Full Text] [Related]
10. Increase in placental glutathione S-transferase in human oral epithelial dysplastic lesions and squamous cell carcinomas.
Zhang L; Xiao Y; Priddy R
J Oral Pathol Med; 1994 Feb; 23(2):75-9. PubMed ID: 8164157
[TBL] [Abstract][Full Text] [Related]
11. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
[TBL] [Abstract][Full Text] [Related]
12. [Alteration of CD44v3 and CD44v6 expression in oral premalignant epithelia].
Gao Y; Liu J; Pang S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):286-8. PubMed ID: 11776894
[TBL] [Abstract][Full Text] [Related]
13. p53 expression in oral precancer and cancer.
Rich AM; Kerdpon D; Reade PC
Aust Dent J; 1999 Jun; 44(2):103-5. PubMed ID: 10452165
[TBL] [Abstract][Full Text] [Related]
14. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
17. The use of thrombomodulin to study epithelial cell differentiation in neoplastic and non-neoplastic oral lesions.
Tabata M; Yonezawa S; Sugihara K; Yamashita S; Maruyama I
J Oral Pathol Med; 1995 Nov; 24(10):443-9. PubMed ID: 8600279
[TBL] [Abstract][Full Text] [Related]
18. CD44v6 in developing, dysplastic and malignant oral epithelia.
Rautava J; Soukka T; Inki P; Leimola-Virtanen R; Saloniemi I; Happonen RP; Heikinheimo K
Oral Oncol; 2003 Jun; 39(4):373-9. PubMed ID: 12676257
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study.
Yan JJ; Tzeng CC; Jin YT
J Oral Pathol Med; 1996 Feb; 25(2):55-9. PubMed ID: 8667256
[TBL] [Abstract][Full Text] [Related]
20. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
